Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-01 Drugs used in obstetrics
| Omega-3-acid ethyl esters |
|
Formulary
|
Capsules 1000mg Preterm birth risk reduction. |
 MHRA: Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors NHSE: NORTH WEST GUIDELINE PRETERM BIRTH |
|
Links
- FSRH Clinical Guideline: Contraceptive Choices for Young People
- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
- LSCMMG: Erectile Dysfunction Guideline
- LSCMMG: Overactive bladder in female adults
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- MHRA: Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors
- NHSE: NORTH WEST GUIDELINE PRETERM BIRTH
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG126: Ectopic pregnancy and miscarriage: diagnosis and initial management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG235: Intrapartum care
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management